Chairman & CEO of Antigenics Inc. (AGEN, Financial) Garo H Armen sells 87,628 shares of AGEN on 03/11/2010 at an average price of $0.79 a share.
Antigenics Inc. has a market cap of $70 million; its shares were traded at around $0.77 with and P/S ratio of 21. Antigenics Inc. had an annual average earning growth of 0.4% over the past 5 years.
Antigenics Inc. has a market cap of $70 million; its shares were traded at around $0.77 with and P/S ratio of 21. Antigenics Inc. had an annual average earning growth of 0.4% over the past 5 years.
CFO Recent Trades:
- Sell:: CFO Shalini Sharp sold 63,848 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has decreased by 9.41% since.
- Sell:: CFO Shalini Sharp sold 63,848 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has decreased by 9.41% since.
Directors and Officers Recent Trades:
- Sell:: VP, Clin, Reg & Quality Kerry Wentworth sold 102,316 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has decreased by 9.41% since.
- Sell:: VP and General Counsel Karen Valentine sold 93,789 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has decreased by 9.41% since.
- Sell:: VP, Finance Christine M Klaskin sold 78,868 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has decreased by 9.41% since.
- Sell:: VP, Clin, Reg & Quality Kerry Wentworth sold 102,316 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has decreased by 9.41% since.
- Sell:: VP and General Counsel Karen Valentine sold 93,789 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has decreased by 9.41% since.
